Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection
Clinical Infectious Diseases2017cited by 146position: middledoi
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon
Mucosal Immunology2017cited by 39position: middledoi